129 related articles for article (PubMed ID: 30051463)
1. Population-based cohort study of diabetes mellitus and mortality in gastric adenocarcinoma.
Zheng J; Xie SH; Santoni G; Lagergren J
Br J Surg; 2018 Dec; 105(13):1799-1806. PubMed ID: 30051463
[TBL] [Abstract][Full Text] [Related]
2. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer.
Koppert LB; Lemmens VE; Coebergh JW; Steyerberg EW; Wijnhoven BP; Tilanus HW; Janssen-Heijnen ML
Br J Surg; 2012 Dec; 99(12):1693-700. PubMed ID: 23132417
[TBL] [Abstract][Full Text] [Related]
3. Prognosis after surgery for gastric adenocarcinoma in the Swedish Gastric Cancer Surgery Study (SWEGASS).
Asplund J; Gottlieb-Vedi E; Leijonmarck W; Mattsson F; Lagergren J
Acta Oncol; 2021 Apr; 60(4):513-520. PubMed ID: 33502275
[TBL] [Abstract][Full Text] [Related]
4. Surgeon age in relation to patients' long-term survival after gastrectomy for gastric adenocarcinoma: nationwide population-based cohort study.
Leijonmarck W; Mattsson F; Asplund J; Markar S; Lagergren J
BJS Open; 2024 Mar; 8(2):. PubMed ID: 38669194
[TBL] [Abstract][Full Text] [Related]
5. Survival Trends in Gastric Adenocarcinoma: A Population-Based Study in Sweden.
Asplund J; Kauppila JH; Mattsson F; Lagergren J
Ann Surg Oncol; 2018 Sep; 25(9):2693-2702. PubMed ID: 29987609
[TBL] [Abstract][Full Text] [Related]
6. Impact of co-morbidity on mortality after oesophageal cancer surgery.
Backemar L; Lagergren P; Johar A; Lagergren J
Br J Surg; 2015 Aug; 102(9):1097-105. PubMed ID: 26059747
[TBL] [Abstract][Full Text] [Related]
7. Weekday of gastrectomy and long-term survival in gastric adenocarcinoma.
Leijonmarck W; Asplund J; Markar SR; Mattsson F; Lagergren J
Eur J Surg Oncol; 2023 Jan; 49(1):83-88. PubMed ID: 35922280
[TBL] [Abstract][Full Text] [Related]
8. Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study.
Holmberg D; Kauppila JH; Asplund J; Leijonmarck W; Mattsson F; Lagergren J
Gastric Cancer; 2024 May; 27(3):590-597. PubMed ID: 38430275
[TBL] [Abstract][Full Text] [Related]
9. Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden.
Sundelöf M; Lagergren J; Ye W
Eur J Cancer; 2008 Jul; 44(11):1566-71. PubMed ID: 18434132
[TBL] [Abstract][Full Text] [Related]
10. Causes of death in patients diagnosed with gastric adenocarcinoma in Sweden, 1970-2014: A population-based study.
Xie SH; Chen H; Lagergren J
Cancer Sci; 2020 Jul; 111(7):2451-2459. PubMed ID: 32359209
[TBL] [Abstract][Full Text] [Related]
11. Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study.
Zheng J; Santoni G; Xie SH; Lagergren J
Br J Cancer; 2021 Jul; 125(2):277-283. PubMed ID: 33972744
[TBL] [Abstract][Full Text] [Related]
12. Changing pattern of histological type, location, stage and outcome of surgical treatment of gastric carcinoma.
Borch K; Jönsson B; Tarpila E; Franzén T; Berglund J; Kullman E; Franzén L
Br J Surg; 2000 May; 87(5):618-26. PubMed ID: 10792320
[TBL] [Abstract][Full Text] [Related]
13. Metformin use and risk of gastric adenocarcinoma in a Swedish population-based cohort study.
Zheng J; Xie SH; Santoni G; Lagergren J
Br J Cancer; 2019 Nov; 121(10):877-882. PubMed ID: 31591459
[TBL] [Abstract][Full Text] [Related]
14. Overall survival before and after centralization of gastric cancer surgery in the Netherlands.
van Putten M; Nelen SD; Lemmens VEPP; Stoot JHMB; Hartgrink HH; Gisbertz SS; Spillenaar Bilgen EJ; Heisterkamp J; Verhoeven RHA; Nieuwenhuijzen GAP
Br J Surg; 2018 Dec; 105(13):1807-1815. PubMed ID: 30132789
[TBL] [Abstract][Full Text] [Related]
15. Impact of metformin on gastric adenocarcinoma survival: A Belgian population based study.
Lacroix O; Couttenier A; Vaes E; Cardwell CR; De Schutter H; Robert A
Cancer Epidemiol; 2018 Apr; 53():149-155. PubMed ID: 29453032
[TBL] [Abstract][Full Text] [Related]
16. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
Le A; Berger D; Lau M; El-Serag HB
Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
[TBL] [Abstract][Full Text] [Related]
17. Survival Rates for Patients with Resected Gastric Adenocarcinoma Finally have Increased in the United States.
Arsoniadis EG; Marmor S; Diep GK; Hui JYC; Jensen EH; Tuttle TM
Ann Surg Oncol; 2017 Oct; 24(11):3361-3367. PubMed ID: 28699133
[TBL] [Abstract][Full Text] [Related]
18. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia.
Kurokawa Y; Sasako M; Sano T; Yoshikawa T; Iwasaki Y; Nashimoto A; Ito S; Kurita A; Mizusawa J; Nakamura K;
Br J Surg; 2015 Mar; 102(4):341-8. PubMed ID: 25605628
[TBL] [Abstract][Full Text] [Related]
19. Prediabetes and diabetes in relation to risk of gastric adenocarcinoma.
Zheng J; Rutegård M; Santoni G; Wallner B; Johansson I; Sund M; Xie SH; Lagergren J
Br J Cancer; 2019 Jun; 120(12):1147-1152. PubMed ID: 31061455
[TBL] [Abstract][Full Text] [Related]
20. Analysis of clinicopathological prognostic parameters in adenocarcinoma of the gastric cardia.
Erturk MS; Ciçek Y; Ersan Y; Saribeyoğlu K; Doğusoy G; Erginoz E
Acta Chir Belg; 2003; 103(6):611-5. PubMed ID: 14743570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
